Issue 3/2010
Content (24 Articles)
Oxidative stress and glucose metabolism—is there a need to revisit effects of insulin treatment?
P. M. Humpert
Optimal dietary approaches for prevention of type 2 diabetes: a life-course perspective
A. E. Buyken, P. Mitchell, A. Ceriello, J. Brand-Miller
Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type 2 diabetes: a nationwide multicentre randomised controlled trial (the Japan Diabetes Complications Study)
H. Sone, S. Tanaka, S. Iimuro, S. Tanaka, K. Oida, Y. Yamasaki, S. Oikawa, S. Ishibashi, S. Katayama, H. Yamashita, H. Ito, Y. Yoshimura, Y. Ohashi, Y. Akanuma, N. Yamada
Effects of glucose level on early and long-term mortality after intracerebral haemorrhage: the Acute Brain Bleeding Analysis Study
S.-H. Lee, B. J. Kim, H.-J. Bae, J. S. Lee, J. Lee, B.-J. Park, B.-W. Yoon
Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study
R. A. DeFronzo, M. A. Banerji, G. A. Bray, T. A. Buchanan, S. Clement, R. R. Henry, A. E. Kitabchi, S. Mudaliar, N. Musi, R. Ratner, P. Reaven, D. C. Schwenke, F. D. Stentz, D. Tripathy
Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of direction
A. García-Patterson, I. Gich, S. B. Amini, P. M. Catalano, A. de Leiva, R. Corcoy
Prediction of postpartum diabetes in women with gestational diabetes mellitus
M. Ekelund, N. Shaat, P. Almgren, L. Groop, K. Berntorp
The gait and balance of patients with diabetes can be improved: a randomised controlled trial
L. Allet, S. Armand, R. A. de Bie, A. Golay, D. Monnin, K. Aminian, J. B. Staal, E. D. de Bruin
Symptoms of depression but not anxiety are associated with central obesity and cardiovascular disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study
J. Labad, J. F. Price, M. W. J. Strachan, F. G. R. Fowkes, J. Ding, I. J. Deary, A. J. Lee, B. M. Frier, J. R. Seckl, B. R. Walker, R. M. Reynolds
Case fatality rates after first acute coronary syndrome in persons treated for type 2 diabetes show an improving trend
K. M. Winell, R. Pääkkönen, A. Pietilä, M. K. Niemi, A. R. Reunanen, V. V. Salomaa
Nocturnal intermittent hypoxia and the development of type 2 diabetes: the Circulatory Risk in Communities Study (CIRCS)
I. Muraki, T. Tanigawa, K. Yamagishi, S. Sakurai, T. Ohira, H. Imano, A. Kitamura, M. Kiyama, S. Sato, T. Shimamoto, M. Konishi, H. Iso
Dysglycaemia and 90 day and 1 year risks of death or readmission in patients hospitalised for community-acquired pneumonia
D. T. Eurich, J. M. Gamble, T. J. Marrie, S. R. Majumdar
The ENPP1 K121Q polymorphism determines individual susceptibility to the insulin-sensitising effect of lifestyle intervention
K. Müssig, M. Heni, C. Thamer, K. Kantartzis, F. Machicao, N. Stefan, A. Fritsche, H.-U. Häring, H. Staiger
NOS1AP variant associated with incidence of type 2 diabetes in calcium channel blocker users in the Atherosclerosis Risk in Communities (ARIC) study
A. Y. Chu, J. Coresh, D. E. Arking, J. S. Pankow, G. F. Tomaselli, A. Chakravarti, W. S. Post, P. H. Spooner, E. Boerwinkle, W. H. L. Kao
Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2β) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: implications for prevention trials
J. De Grijse, M. Asanghanwa, B. Nouthe, N. Albrecher, P. Goubert, I. Vermeulen, S. Van Der Meeren, K. Decochez, I. Weets, B. Keymeulen, V. Lampasona, J. Wenzlau, J. C. Hutton, D. Pipeleers, F. K. Gorus
Human IL6 enhances leptin action in mice
M. Sadagurski, L. Norquay, J. Farhang, K. D’Aquino, K. Copps, M. F. White
Thiazolidinediones increase the wingless-type MMTV integration site family (WNT) inhibitor Dickkopf-1 in adipocytes: a link with osteogenesis
B. Gustafson, B. Eliasson, U. Smith
Human ATP synthase beta is phosphorylated at multiple sites and shows abnormal phosphorylation at specific sites in insulin-resistant muscle
K. Højlund, Z. Yi, N. Lefort, P. Langlais, B. Bowen, K. Levin, H. Beck-Nielsen, L. J. Mandarino
The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice
J. Hsieh, C. Longuet, C. L. Baker, B. Qin, L. M. Federico, D. J. Drucker, K. Adeli
Regulation of oxidative stress by glycaemic control: evidence for an independent inhibitory effect of insulin therapy
L. Monnier, C. Colette, E. Mas, F. Michel, J. P. Cristol, C. Boegner, D. R. Owens
A novel primate model of delayed wound healing in diabetes: dysregulation of connective tissue growth factor
S. E. Thomson, S. V. McLennan, A. Hennessy, P. Boughton, J. Bonner, H. Zoellner, D. K. Yue, S. M. Twigg
Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes
A. Koïtka, Z. Cao, P. Koh, A. M. D. Watson, K. C. Sourris, L. Loufrani, A. Soro-Paavonen, T. Walther, K. J. Woollard, K. A. M. Jandeleit-Dahm, M. E. Cooper, T. J. Allen